Applicants,Chemical_Name,Funding_requested_for,Pharmaceutical,Schedules,Therapeutic_group
ABBVIE LIMITED,Upadacitinib,"Psoriatic arthritis, 2nd line biologic",Upadacitinib (RINVOQÂ®),Community,Oncology Agents and Immunosuppressants
